Skip to Content

TL 385 TL 385 (Terazosin 5 mg)

Pill imprint TL 385 TL 385 has been identified as Terazosin hydrochloride 5 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Terazosin hydrochloride 5 mg TL 385 TL 385
Terazosin hydrochloride 5 mg TL 385 TL 385
Terazosin hydrochloride
TL 385
TL 385
5 mg
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
National Drug Code (NDC):
Inactive Ingredients:
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
corn starch
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Red No. 40
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67544-0563 Prepak Systems Inc (repackager)
21695-0813 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.